AI-CVD vs Imbio PHA (4.0.0)
AI Verdict
Choose AI-CVD if…
Choose AI-CVD if your primary goal is broad, opportunistic screening for a wide array of cardiovascular and multisystem disease risks using existing chest and abdominal CT scans. This tool is ideal for identifying hidden health concerns like coronary artery calcium, cardiac chamber abnormalities, and epicardial fat volumetry without requiring additional imaging or disrupting current workflows.
View AI-CVD →Choose Imbio PHA (4.0.0) if…
Choose Imbio PHA if you need specialized, automated analysis of CT pulmonary angiogram (CTPA) scans to assess right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. This tool is specifically designed to provide rapid, accurate measurements of cardiac structures and ratios (like RV/LV and PA/Ao) critical for evaluating acute and chronic cardiopulmonary conditions.
View Imbio PHA (4.0.0) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AI-CVD | Imbio PHA (4.0.0) |
|---|---|---|
| Deployment | Unknown | Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). |
| FDA Status | Unknown | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AI-CVD | Imbio PHA (4.0.0) |
|---|---|---|
| Name | AI-CVD | Imbio PHA (4.0.0) |
| Company | HeartLung Corporation | Imbio |
| Description | FDA-cleared, AI-powered quantitative imaging platform that performs opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden health risks. | FDA-cleared AI-powered medical image processing software that automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. |
| Key Features | Automated CT-derived anatomical and density-based measurements, Opportunistic screening from existing chest and abdominal CT scans, No additional imaging, radiation, contrast, or workflow disruption, Coronary Artery Calcium (CAC) scoring, Aortic wall, aortic valve, and mitral valve calcium analysis, Cardiac chamber volumetry (Left Atrium, Left Ventricle, Right Atrium, Right Ventricle), Epicardial fat volumetry, Aorta and pulmonary artery sizing | Automated measurement of right and left ventricle diameters, Automated measurement of main pulmonary artery and aorta diameters, Calculates RV/LV and PA/Ao ratios, Utilizes artificial intelligence algorithms for anatomical identification and measurement, Generates annotated DICOM images, Provides summary reports in PDF format, Integrates with native DICOM tools and workflows, Rapid, fully-automated assessment (typically in minutes) |
| Categories | Cardiology AI | Cardiology AI, Radiology & Imaging AI |
| Specialties | Cardiology, Pulmonology, Radiology | Cardiology, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring AI-CVD and Imbio PHA (4.0.0).